Skip to main content
logo
Obsidian Therapeutics, Inc. (OBX)
NASDAQ: OBX · Real-Time Price · USD
35.00
+7.50 (27.27%)
At close: Aug 10, 2026, 4:00 PM EDT
35.70
+0.70 (2.00%)
After-hours: Aug 10, 2026, 6:18 PM EDT

Obsidian Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Cash & Equivalents
26.4440.4149.76
Short-Term Investments
32.3240.08118.51
Cash & Short-Term Investments
58.7680.49168.27
Cash Growth
--52.17%-
Prepaid Expenses
4.581.034.58
Total Current Assets
64.0481.52172.85
Property, Plant & Equipment
5.096.069.86
Other Long-Term Assets
111
Total Assets
70.1488.58183.71

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Accounts Payable
0.740.011.82
Accrued Expenses
10.3810.8810.3
Current Portion of Leases
2.533.062.99
Other Current Liabilities
1.581.420.98
Total Current Liabilities
15.2315.3616.09
Long-Term Leases
1.071.223.82
Other Long-Term Liabilities
000.21
Total Liabilities
16.3116.5920.12

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
39.3729.8720.92
Retained Earnings
-315.57-295.94-195.33
Comprehensive Income & Other
-0.010.02-0.03
Total Common Equity
-276.2-266.04-174.43
Shareholders' Equity
53.8371.99163.6
Total Liabilities & Equity
70.1488.58183.71

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Total Debt
3.64.286.81
Net Cash (Debt)
55.1576.2161.46
Net Cash Growth
--52.80%-
Net Cash Per Share
745.251557.42-
Filing Date Shares Outstanding
21.0913.94-
Total Common Shares Outstanding
21.0913.94-
Working Capital
48.8166.15156.76
Book Value Per Share
-13.10-19.08-
Tangible Book Value
-276.2-266.04-174.43
Tangible Book Value Per Share
-13.10-19.08-
Machinery
-10.7810.7
Leasehold Improvements
-0.260.26
SEC Filings: 10-K · 10-Q